SkyNano is a science-driven company pioneering a sustainable pathway to produce low-cost advanced carbon-based materials directly from carbon dioxide.
Using a proprietary electrochemical process developed at Vanderbilt University, SkyNano captures CO2 from industrial emissions and converts it into valuable solid carbon nanomaterials—without fossil feedstocks.
Tricuspid regurgitation (TR) is the most common valvular heart disease, affecting more than 20 million people in the US, including 1.8 million with severe dysfunction.
TR occurs when the tricuspid valve fails to close properly, allowing blood to flow backward from the right ventricle to the right atrium. As severity increases, the heart works harder, leading to reduced quality of life, end-organ dysfunction, and higher mortality.
Falcomm is a fabless semiconductor company based in Atlanta, Georgia, specializing in ultra-efficient integrated power amplifiers (PAs) and front-end modules that significantly reduce power consumption and size in wireless and satellite systems.
30 million Americans suffer from food allergies, with 6 million affected by peanut allergy—a life-threatening condition with no robust, disease-modifying treatments widely adopted.
Current management relies on strict avoidance and emergency epinephrine, leaving patients and families in constant fear of accidental exposure.
